The text provides an overview of the financial statements of The Procter & Gamble Company and its subsidiaries for the specified periods. It includes details on net sales, operating income, earnings before income taxes, net earnings, comprehensive income, balance sheets, consolidated statements of shareholders' equity, cash flows, segment information, goodwill, intangible assets, earnings per share, share-based compensation, postretirement benefits, risk management activities, fair value measurements, currency hedging, derivatives, accumulated other comprehensive income/loss, as well as commitments and contingencies. The company's financial performance, segment details, and risk management strategies are discussed, along with notes on accounting policies, disclosures, and future uncertainties like litigation and tax matters.
The presented text provides a detailed overview, analysis, and financial data related to Procter & Gamble's business segments, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. Financial performance metrics and growth factors are discussed for the three and nine months ended March 31, 2023, comparing data from the same periods in 2022. The document also includes information on forward-looking statements, risks and uncertainties, and details on non-GAAP measures used by the company. Relevant figures include net sales growth percentages, net earnings, diluted net earnings per share, operating cash flow, capital spending, and adjusted free cash flow, among other financial data points, providing insights into Procter & Gamble's financial health and operational activities during the stated periods.
The text states that there have been no significant changes in the company's exposure to market risk since June 30, 2022. More details about the company's risk management activities and fair value measurements can be found in Note 9 of the Consolidated Financial Statements.
The text provides information on the evaluation of disclosure controls and procedures conducted by the Chairman, President, CEO, and CFO of a company, confirming that the controls and procedures were effective in ensuring timely and accurate disclosure of required information in reports filed under the Exchange Act. Additionally, it states that there were no significant changes in the internal control over financial reporting during the company's fiscal quarter ending March 31, 2023.
The Company outlines in their statement that they are occasionally involved in legal proceedings and claims related to various aspects of their business, such as antitrust, product liability, and employment issues. They also mention the requirement to disclose environmental proceedings with potential significant monetary sanctions, but state that there are no relevant matters to report under this item for the current period.
Refer to the risk factors outlined in Part I, Item 1A of the Company's Form 10-K for the fiscal year ending June 30, 2022, for detailed information on potential risks.
The text provides details on the unregistered sales of equity securities by a company, including the amount of shares purchased, average prices paid per share, publicly announced share repurchase plans, and the approximate dollar value of shares yet to be purchased under the share repurchase program. The company has made significant purchases of its own shares in the open market through large financial institutions and plans to reduce outstanding shares through direct share repurchases totaling $7.4 to $8 billion in fiscal year 2023, funded by a combination of operating cash flows and debt issuance.
I'm sorry, but it looks like the text parts were not provided. Could you please resend the text that needs to be summarized?
I'm sorry, but it appears that I have not received any text parts from you yet. Could you please resend them so that I can provide you with a summarized version of the text?
I'm ready to summarize the text now that I have received all the parts. Please go ahead and provide the text you would like me to summarize.
The text provides information about various exhibits related to the company, including the Amended Articles of Incorporation and Regulations approved by the Board of Directors. It also includes certifications by the Chief Executive Officer and Chief Financial Officer, as well as Inline XBRL documents. Additionally, it mentions a Separation Letter and Release form and states that the information provided is furnished and not filed for specific liability purposes under certain sections of the Securities Acts. The signing authority for this report is Matthew W. Janzaruk, Senior Vice President and Chief Accounting Officer, on behalf of The Procter & Gamble Company on April 21, 2023.
